Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.70 |
| ▸ | CA2 | P00918 | 7/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | DHFR | P00374 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | FBP1 | P09467 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 3/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15650208 | 0.84 | ALDH1A1 (0.69) | CA1CA2ALDH1A1DHFRTSHR | |
| SCHEMBL4819815 | 0.84 | ALDH1A1 (0.64) | CA1CA2ALDH1A1DHFRTSHR | |
| SCHEMBL6850444 | 0.84 | EGFR (0.68) | CA1CA2ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL13537908 | 0.84 | CA1 (0.68) | CA1CA2ALDH1A1TSHRTDP1 | |
| SCHEMBL3928646 | 0.84 | EGFR (0.68) | CA1CA2ALDH1A1MMP1MMP2 | |
| SCHEMBL3928657 | 0.83 | CA1 (0.67) | CA1CA2SMN1; SMN2MEN1LMNA | |
| SCHEMBL5458800 | 0.81 | ALDH1A1 (0.65) | CA1CA2ALDH1A1DHFRTSHR | |
| SCHEMBL6848813 | 0.81 | CA1 (0.64) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL6850082 | 0.81 | CA1 (0.64) | CA1CA2ALDH1A1TDP1MMP1 | |
| SCHEMBL3928427 | 0.80 | EGFR (0.63) | CA1CA2ALDH1A1LMNAMMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7625917-B2 | S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein | TURPIN JAMES A | 2009-12-01 | — | — | US | disclosed |
| EP-1087941-B9 | THIOLESTERS AND USES THEREOF | US HEALTH (US) | 2007-11-07 | — | — | EP | disclosed |
| EP-1087941-B1 | THIOLESTERS AND USES THEREOF | US HEALTH (US) | 2006-08-16 | — | — | EP | disclosed |
| US-20040132785-A1 | Thiolesters and uses thereof | The Government of the U. S.of America as Represented by The Sec. of Health and Human Svc. (US) | 2004-07-08 | — | — | US | disclosed |
| US-6706729-B1 | A METHOD FOR DISSOCIATING A METAL ION FROM A ZINC FINGER-CONTAINING PROTEIN; INHIBITING VIRUS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-03-16 | — | — | US | disclosed |
| EP-1087941-A2 | THIOLESTERS AND USES THEREOF | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999065871-A2 | THIOLESTERS AND USES THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132785-A1 | Thiolesters and uses thereof | SARS1, HAVCR2, P4HB | CA1 3728/4885CA2 4550/4885ALDH1A1 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.